U.S. Markets close in 6 hrs 16 mins

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
70.15+1.78 (+2.60%)
As of 9:44AM EDT. Market open.

Moderna, Inc.

200 Technology Square
Cambridge, MA 02139
United States
617 714 6500
http://www.modernatx.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees975

Key Executives

NameTitlePayExercisedYear Born
Dr. Noubar B. Afeyan Ph.D.Co-Founder, Independent Non Exec. Chairman & Member of Technology Advisory Board105kN/A1963
Mr. Stéphane BancelCEO & Director1.95MN/A1973
Dr. Stephen HogePres1MN/A1976
Dr. Tal ZaksChief Medical Officer832.43kN/A1966
Mr. Juan AndresChief Technical Operations & Quality Officer862.57kN/A1965
Mr. David W. MelineCFO & Principal Accounting OfficerN/AN/A1957
Dr. John V. W. ReyndersChief Information OfficerN/AN/AN/A
Dr. Melissa J. MooreChief Scientific Officer & Member of Scientific Advisory BoardN/AN/AN/A
Ms. Lavina Talukdar CFAHead of Investor RelationsN/AN/AN/A
Ms. Lori M. Henderson J.D., Esq.Gen. Counsel & Corp. Sec.N/AN/A1962
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. As of February 15, 2019 the company had 11 programs in clinical trials and a total of 20 development candidates in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca, Merck & Co., Vertex Pharmaceuticals, Biomedical Advanced Research and Development Authority, Defense Advanced Research Projects Agency, and Bill & Melinda Gates Foundation; and a research collaboration with Harvard University. Moderna, Inc. also has collaborations with Lonza Ltd. for the manufacture of mRNA-1273, a COVID-19 vaccine; and Catalent for fill-finish manufacturing of its COVID-19 vaccine candidate. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Moderna, Inc.’s ISS Governance QualityScore as of October 6, 2020 is 8. The pillar scores are Audit: 5; Board: 8; Shareholder Rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.